SPRY
NASDAQ · Biotechnology
Ars Pharmaceuticals Inc
$7.57
-2.97 (-28.18%)
Analyst Consensus
Strong Buy
11
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+770.7% upside
Low Target
$44.11
Average Target
$65.91
High Target
$67.85
Current Price
$7.57
Current
$7.57
$7.57
Target
$65.91
$65.91
$44.11
$65.91 avg
$67.85
Scenario Analysis
Bear Case
$44.11
482.7%
Low target
Base Case
$65.91
+770.7%
Avg target
Bull Case
$67.85
+796.3%
High target
Risk/Reward
1.6x
Balanced
Price in Context
52-Week High
$18.90
-59.9% from high
52-Week Low
$6.66
+13.7% from low
Target vs 52W High
$65.91
+248.7% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 40 | 78% | $257.58 | +5.7% |
| AMGN | Hold | 44 | 50% | $190.87 | -46.4% |
| GILD | Strong Buy | 39 | 82% | $362.68 | +191.5% |
| VRTX | Strong Buy | 40 | 83% | $438.34 | -9.5% |
| REGN | Buy | 38 | 71% | $76.80 | -87.7% |
| ALNY | Strong Buy | 37 | 76% | $102.31 | -65.0% |
| RVMD | Strong Buy | 27 | 96% | $114.11 | -32.8% |
| NTRA | Strong Buy | 27 | 89% | $142.91 | -45.0% |